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Abstract
Background: Results from hemolyzed, icteric, and
lipemic samples may be inaccurate and can lead to
medical errors. These preanalytical interferences may
be detected using visual or automated assessment.
Visual inspection is time consuming, highly subjec-
tive and not standardized. Our aim was to assess
the comparability of automated spectrophotometric
detection and visual inspection of lipemic, icteric and
hemolyzed samples.
Methods: This study was performed on 1727 routine
biochemistry serum samples. Automated detection
was performed using the Olympus AU2700 analyzer.
We assessed: 1) comparability of visual and automat-
ed detection of lipemic, icteric and hemolyzed sam-
ples, 2) precision of automated detection, and
3) inter-observer variability for visual inspection.
Results: Weighted k coefficients for comparability of
visual and automated detection were: 0.555, 0.529
and 0.638, for lipemic, icteric and hemolyzed samples,
respectively. The precision for automated detection
was high for all interferences, with the exception of
samples being only slightly lipemic. The best overall
agreement between observers was present in assess-
ing lipemia (mean weighted ks0.698), whereas the
lowest degree of agreement was observed in assess-
ing icterus (mean weighted ks0.476).
Conclusions: Visual inspection of lipemic, icteric and
hemolyzed samples is highly unreliable and should
be replaced by automated systems that report serum
indices.
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Introduction
Most errors occur in the preanalytical phase of clinical
laboratory testing (1, 2). Successful monitoring and
management of preanalytical sources of interferences
is therefore crucial to the quality of laboratory diag-
nostic process and to the quality of patient care.
Results from hemolyzed, icteric, and lipemic samples
may be inaccurate and can lead to medical errors, and
as such represent a considerable hazard to patient
health (3, 4). Modern clinical chemistry analyzers are
equipped with automated systems for detection of
lipemic, icteric, and hemolyzed samples. With contin-
uous technological development and laboratory auto-
mation, a significant reduction in laboratory errors
can be expected (5, 6). However, in laboratories that
do not use automated systems for detection and
management of preanalytical interferences, unsuit-
able samples are detected by means of visual inspec-
tion by individual laboratory personnel. Visual
inspection is not only time consuming, but also high-
ly subjective, non-standardized and may be a poten-
tial source of error (7, 8). Our goal was to assess the
comparability of automated spectrophotometric detec-
tion and visual inspection of lipemic, icteric and
hemolyzed samples. Automated detection was per-
formed using the Olympus AU2700 (Olympus, Tokyo,
Japan) clinical chemistry analyzer with the manufac-
turer’s reagents. To the best of our knowledge, this
type of study has not yet been performed.
Materials and methods
The University Department of Chemistry is an ISO 15189
accredited central laboratory at the tertiary care 900 bed Uni-
versity Hospital Sestre Milosrdnice, in Zagreb, Croatia. The
laboratory has a capacity of up to 3 million tests per year.
All comparisons were performed in our laboratory during
July 2008. We assessed the following: 1) comparability of
visual and automated detection of lipemic, icteric and hemo-
lyzed samples, 2) precision of the Olympus LIH reagent
(Olympus, O’Callaghan’s Mills, Co. Clare, Ireland), and
3) inter-observer variability for visual inspection of samples.
Comparability of visual and automated detection
The comparability assessment was performed using 1727
consecutive routine biochemistry serum samples. We used
routine in-patient hospital serum samples collected outside
the laboratory by the clinical staff. Blood was obtained by
venipuncture and collected in evacuated BD Vacutainer
glass tubes without any additive (Becton-Dickinson, Franklin
Lakes, NJ, USA). Samples were centrifuged at 3500 g for
10 min. After centrifugation, serum was inspected visually
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Table 1 Degrees of interference assessed visually and by use of the LIH Olympus reagent, and the corresponding
concentration of the interfering substance.
Interference degree 0 1 2
Lipemia
Visual No Mild Severe
LIH N q (2q)–(5q)
Intralipid, g/La -0.4 0.4–1 )1
Icteria
Visual No Mild Severe
LIH N (q)–(2q) (3q)–(5q)
Bilirubin, mmol/La -42.7 mmol/L 42.7–169.3 mmol/L )169.3 mmol/L
Hemolysis
Visual No Mild Severe
LIH N q (2q)–(5q)
Hemoglobin, g/La -0.5 g/L 0.5–1 g/L )1 g/L
aAccording to the manufacturer (Olympus).
Table 2 Number of samples flagged by the LIH Olympus
reagent as ABN (excluded from further analysis) with differ-
ent degrees of interference (assessed by visual inspection).
Visual inspection
0 1 2
Lipemia, n 19 4 –
Icteria, n 20 2 1
Hemolysis, n 10 10 3
ABN, abnormal.
by one observer who was informed about the study. After-
wards, the samples were processed for automated detection
using the LIH reagent. The LIH reagent uses a semiquanti-
tative spectrophotometric measurement and grades interfer-
ing substances into one of six categories: normal (N),q, 2q,
3q, 4q and 5q. The spectrophotometric measurement is
performed at the following wavelengths (nm): 660 and 800
for lipemia, 480, 570, 600 and 800 for icterus and 410, 480,
600 and 800 for hemolysis. Visual inspection was performed
according to our written standard operating procedure for
the detection and management of unsuitable specimens.
The visual procedure uses standardized colored diagrams
with different intensities of lipemia, icterus and hemolysis
with the respective concentration of the interfering sub-
stance. Interference grading was done according to Table 1.
Precision of Olympus LIH reagent
Within-run precision was determined using patient samples
measured 20 times in series. Two patient samples were used
for each interference with following concentrations: 8.56
mmol/L and 38.8 mmol/L triglycerides for lipemia,
113.7 mmol/L and 317.6 mmol/L bilirubin for icterus and
-1 g/L and 3.5 g/L hemoglobin for hemolysis.
Inter-observer variability for visual inspection
Inter-observer variability of laboratory personnel for visual
inspection was examined using a series of 25 serum sam-
ples. We compared the results obtained by five different ran-
domly selected laboratory technicians with the individual
who visually inspected all samples for the purpose of this
study. All observers were informed about the purpose of the
procedure. k coefficients with respective 95% confidence
intervals (CI) were calculated for interference detected by
each observer.
Statistical analysis
Data were presented as numbers (counts) and percentages.
Inter-observer agreement was assessed using a weighted
k coefficient. Interpretation of the k coefficient was as fol-
lows: -0: less than chance agreement; 0.01–0.20: slight
agreement; 0.21–0.40: fair agreement; 0.41–0.60: moderate
agreement; 0.61–0.80: substantial agreement; 0.81–0.99:
almost perfect agreement (9). Precision was expressed as
the coefficient of variation (CV%). Statistical analysis was
performed using MedCalc statistical software (MedCalc
10.1.3.1, Frank Schoonjans, Mariakerke, Belgium).
Results
Out of 1727 samples, 23 (23/1727s1.3%) were flagged
as ABN (abnormal) by the Olympus reagent (Table 2).
According to the manufacturer’s instructions, sam-
ples flagged as ABN need to be re-run and/or visually
examined. We excluded these samples from further
analysis.
Comparability of visual and automated detection
A total of 57 lipemic samples were identified by visual
inspection, while automated LIH detection found 35
lipemic samples only (Table 3). The weighted k coef-
ficient was 0.555 (95% CIs0.419–0.691) indicating
moderate overall agreement.
A total of 101 icteric samples were identified by
visual inspection, while automated LIH detection
revealed only 74 icteric samples. Visual inspection
and automated LIH detection identified a similar pro-
portion of mild and severely icteric samples (Table 4).
The weighted k coefficient was 0.529 (95% CIs
0.427–0.630), showing moderate agreement.
The best comparability was achieved when assess-
ing the grade of hemolysis. Visual inspection and
automated LIH detection showed a comparable rate
of detection for hemolyzed samples (Table 5). The
weighted k coefficient was 0.638 (95% CIs0.569–
0.707), showing substantial agreement.
Precision of Olympus LIH reagent
Within-run precision (CV) of the LIH reagent was as
follows: 0% and 55% at 38.8 and 8.56 mmol/L triglyc-
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Table 3 Comparison of visual inspection and LIH Olympus reagent for lipemia.
LIH Olympus Visual inspection
reagent
0 1 2
0 1642 27 0 1669 (97.9%)
1 5 27 7 33 (1.9%)
2 0 1 1 2 (0.1%)
1647 (96.7%) 49 (2.9%) 8 (0.5%) 1704
Table 4 Comparison of visual inspection and LIH Olympus reagent for icterus.
LIH Olympus reagent Visual inspection
0 1 2
0 (n) 1586 41 3 1630 (95.7%)
1 (q and qq) 17 31 11 59 (3.5%)
2 (3q to 5q) 0 7 8 15 (0.9%)
1603 (94.1%) 79 (4.6%) 22 (1.3%) 1704
Table 5 Comparison of visual inspection and LIH Olympus reagent for hemolysis.
LIH Olympus Visual inspection
reagent
0 1 2
0 1529 26 1 1556 (91.3%)
1 27 59 18 104 (6.1%)
2 2 25 17 44 (2.6%)
1558 (91.4%) 110 (6.5%) 36 (2.1%) 1704
Table 6 k Coefficients with respective 95% CI for five randomly selected laboratory technicians.
B C D E F Mean k
k (95% CI) k (95% CI) k (95% CI) k (95% CI) k (95% CI)
Haemolysis 0.584 0.726 0.622 0.569 0.583 0.617
(0.295–0.874) (0.480–0.972) (0.318–0.916) (0.268–0.870) (0.293–0.874) (0.537–0.696)
Lipemia 0.743 0.643 0.743 0.627 0.732 0.698
(0.470–1.016) (0.322–0.964) (0.470–1.016) (0.292–0.962) (0.448–1.016) (0.626–0.769)
Icteria 0.655 0.594 0.160 0.446 0.527 0.476
(0.345–0.965) (0.276–0.912) (–0.321–0.640) (0.098–0.794) (0.197–0.857) (0.237–0.716)
Mean k 0.661 0.654 0.508 0.547 0.614
(0.463–0.859) (0.489–0.820) (–0.256–1.273) (0.318–0.777) (0.351–0.877)
erides for lipemia, 0% and 0% at 317.6 and 113.7
mmol/L bilirubin for icterus and 0% and 10% at 3.5
and -1 g/L hemoglobin for hemolysis. All samples
that were not classified correctly were flagged as
ABN.
Inter-observer variability for visual inspection
Data on inter-observer variability are shown in Table
6. Five randomly selected laboratory technicians were
marked as B-F. The reference technician was marked
as A, and all k coefficients (with respective 95% CI)
were calculated in comparison to technician A. The
best overall agreement between observers was in the
assessment of lipemia. The mean weighted k value
for lipemia was 0.698 (95% CIs0.626–0.769). The low-
est degree of agreement was observed in assessing
icterus (weighted ks0.476, 95% CIs0.237–0.716).
Discussion
Unsuitable specimens may significantly affect the
accuracy of many clinical chemistry and hematology
analyses (10, 11). Successful detection and manage-
ment of such specimens is one of the major tasks in
medical laboratories and an obligation and responsi-
bility for every laboratory accredited according to ISO
15189 standard (12, 13). The prevalence of hemolyzed
specimens might be a suitable indicator of preanaly-
tical quality. Hemolysis is most often caused by inad-
equate specimen collection or sample handling, and
occurs with varying prevalence in different health
care settings (14). The aim of this study was to
explore the agreement between visual and automated
detection of lipemic, icteric and hemolyzed samples.
Published data on this issue are not common. The key
finding of this work is that visual inspection is inferior
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compared with automated detection of preanalytical
interferences, such as lipemia, icterus and hemolysis.
Poor inter-rater agreement between our observers
provides evidence that the human eye is not able to
accurately and reproducibly detect subtle differences
in sample color and turbidity, even when a standard
operating procedure and colored scale are available.
Given that only moderate overall agreement exists
between visual and automated detection, and the
poor inter-observer agreement, laboratories should
not be confident relying on manual visual detection
of lipemic, icteric and hemolyzed specimens. Auto-
mated systems should be employed and there should
be a standard protocol for managing unsuitable sam-
ples. Laboratory staff should be continually trained
and educated about the importance of the preanaly-
tical quality of laboratory analysis.
The automated detection using the LIH reagent with
the AU2700 Olympus analyzer provides precise
observations for almost all interfering substances,
with the exception of mild lipemia where the LIH
showed rather high imprecision. In addition, only
1.3% of samples were flagged as abnormal and
required re-assessment. In these instances, visual
inspection is irreplaceable.
Lippi et al. compared the efficiency of different ana-
lytical platforms for identifying hemolyzed specimens
(15). They found that overall imprecision was satis-
factory. However, the authors conclude that more
effort should be invested in standardizing the way
that different laboratories report hemolysis (15).
While there are several reports on the performance
of visual and automated detection of hemolyzed sam-
ples, information on the agreement of visual assess-
ment and spectrophotometric detection of lipemia
and icterus is lacking, as is data on inter-observer
agreement. Our results are most consistent with
those reported previously by other investigators.
Glick et al. examined the accuracy of visual detection
of turbidity, hemolysis and icterus in comparison to
the measurement triglyceride, hemoglobin and bili-
rubin concentrations (8). The authors used full color
photographs with a scale of six possible grades of
interference (trace, 1q, 2q, 3q, 4q and 5q) for visu-
al detection. Their conclusion was that visual esti-
mation was unreliable. However, it should be noted
that sample turbidity only weakly correlates with tri-
glyceride concentration (16), making interpretation of
the results by Glick et al. on the accuracy of visual
detection of turbidity somewhat questionable.
Another study performed by Hawkins assessed the
discrepancy between visual grading and automated
hemolysis measurements on the Roche 917 clinical
chemistry analyzer (7). Technical staff performing the
visual assessment of samples was not informed
about the investigation being carried out. For purpos-
es of the study, comments on 800 serum general
chemistry results and 800 plasma troponin I results
were collected and consolidated with the H index.
Hemolysis was overestimated using visual assess-
ment of serum samples and underestimated in plas-
ma samples. The conclusion of this study was that
visual assessment of sample hemolysis is unreliable.
Since laboratory personnel was not informed about
the study, this observation however does not provide
evidence for agreement between visual grading and
spectrophotometric determination of the H index
measurement. Instead it illustrates the general atti-
tude of the staff towards the importance of hemoly-
sis. Lipemia and icterus interference was not analyzed
in this study.
Jeffery et al. compared detection of hemolysis in
adult and neonatal samples by inspection and meas-
urement of H index (17). They found that the presence
of icterus in neonatal samples decreases the ability
to detect hemolysis by visual inspection. Based on
their results, the authors conclude that the use of the
automated hemolysis index is highly recommended
and that potassium in neonatal and adult specimens
should be reported with a correction formula, since it
might be beneficial to the clinical management of the
patient.
One important aspect should also be stressed,
namely, the progressive automation and integration
of various segments of the total testing process. Such
integration of preanalytical modules and analytical
workstations would make it difficult to check the
specimens before processing. This is why systematic
(i.e., automated) inspection for interferences is highly
advisable.
Another important issue not covered in our study
is the appropriate action taken by the laboratory per-
sonnel when interference is detected. There is an
ongoing debate as to whether such result should be
reported with a comment, corrected or withheld by
the laboratory (18). Unfortunately, there is little evi-
dence to support interpretation of laboratory test
results and interpretative comments accompanying
laboratory reports as a contribution to the outcome of
the patient and the quality of the patient care (19, 20).
Large well-designed studies assessing the outcome of
the patient are needed to define the most appropriate
actions to be taken in these instances.
Given the importance of preanalytical interferences
as one of the most common sources of laboratory
errors, we conclude that visual inspection of lipemic,
icteric and hemolyzed samples is highly unreliable
and should be replaced by automated systems report-
ing serum indices. Future studies should define sim-
ple algorithms for mathematical correction of test
results for interference of hemoglobin, bilirubin and
lipids (21).
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